Forskningssamverkan –olika
modeller
Stockholm, May 23 2017
Amy Leval, Outcomes Research Manager, Med Dr
Epidemiologi, Janssen
Interactive Visualization
- Visualizing Prostate Cancer Testing and Outcomes -
Who are we?
Olof
Akre
Markus
Aly
Sandra
Eloranta
Amy
Leval
Johan
Liwing
Mario
Romero
Urologist
Professor KI
Urologist,
Ph.D.
Karolinska
University
Hospital
Researcher
Med. Sci. KI
Researcher
Janssen
Visualization
Professor KTH
sandra.eloranta
@ki.se
[email protected]
J.com
RWE
Partnerships
Janssen
[email protected]
e
Markus.Aly@ki
.se
[email protected]
[email protected]
m
To be
continued…
From collaborative visualization to
collaborative analytics
OHDSI community
•>140 researcher institutions in
academia, industry, government,
health systems
• Common data model (OMOP)
•>20 countries
•>660 million patients
Collaborative analytics – current possibility,
future standard?
11 data sources, 4 countries, 250 million patients
Common data modell.
Dela på protokoll,
analysresultat, inte på
individdata!
Yet another way to collaborate….
11
12
13
Janssen’s global real world evidence network
By analyzing a broader range of
parameters, real world evidence
research can uncover outcomes, unmet
needs and clues to future medical
breakthroughs.
Janssen is partnering with top institutions
world wide to accelerate this new line of
research.
Sweden
Canada
Hungary
USA
Our network aims to:
Korea
Taiwan
Apply scientific best practices
Advance methodologies
Generate evidence about disease pathways,
healthcare delivery, and the effects of medical
interventions
Support medical decisions and identify new
medical breakthroughs
14
Unique opportunity for Nordic life science
Real world evidence will impact all
phases of medical research and
therapeutic development.
Thanks to its data infrastructure, the Nordic
region can become a hot-spot for advanced
medical research by enabling uniquely
comprehensive and long term studies.
Janssen is partnering with Karolinska
Institutet in a major collaborative research
initiative that focuses on:
Treatment resistant depression
Prostate cancer
Psoriasis
B-Cell malignancies
Methodology development
Janssen’s real world evidence network also
facilitates collaboration in other disease areas,
across Nordic institutions.
10%
Of all global real world evidence
research originates from Sweden.
Other Nordic countries are also
generating an extensive proportion.
15
Broad collaboration:
Johnson & Johnson Innovation + Karolinska Institutet
Launched 22 May 2015
A broad and unique industry-academia collaboration in the Nordic region to:
• advance medical research
• nurture emerging healthcare companies
•
accelerate development of breakthrough products for improved treatment outcomes
To support the collaboration Johnson & Johnson Innovation opened a life science
innovation office at Karolinska Institutet.
Commercial knowledge
Resources
Coaching
Investment
Seed-financing
Innovation
•Academic focus (KI Innovations AB)
Abundance of early-stage science
excellence
World class life sciences research
•Prestige
•History Nordic influence
“IMI is the world's biggest public-private partnership (PPP) in the life
sciences. Through the IMI 2 programme, it has a €3.3 billion budget for the
period 2014-2024.”
17
IMI’s Big Data for Better Outcomes (BD4BO)
Samverkan – topp 3 checklista
1.Förståelse kring den vetenskapliga frågeställningen
2.Uppskatta kompetens hos olika team
- ta in mer extern kompetens vid behov…
3.Kontrakt, och tid för kontrakt och process
19
Samverkan för att utveckla life science
Det finns flera modeller
20
